A new phase 1 clinical trial has found that an emerging immunotherapy is promising for treating recurrent glioblastoma, a ...
By using mRNA molecules to “remodel” parts of the immune system, researchers generated T cells that can slow the growth of ...
People who live to 110 years and older have large populations of a rare type of immune cell that can kill cancer 1, finds a ...
Influenza continues to cause major illness each year in the United States, leading to more than 35,000 deaths annually.
Final phase 1 results showed lasting responses to soquelitinib in some patients with relapsed or refractory T cell lymphoma.
Researchers have found a way to supercharge natural killer cells, powerful immune cells that can attack cancer, so they can ...
In the setting of Alzheimer’s and other neurodegenerative diseases, do T cells make things better, or worse? A simple answer just won’t do—it likely depends on the type of T cells, where they are in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results